Objective: To compare the prevalence of vitamin A deficiency (VAD) among Cambodian preschool children as determined by the retinol-binding protein-enzyme immunoassay (RBP-EIA) and direct measurement of serum retinol by high-performance liquid chromatography (HPLC). Setting and subjects: Sera from 359 children were randomly selected from archived specimens collected in a national VAD prevalence survey in Cambodia. Methods: Sera were first analyzed for retinol content by HPLC and then subjected to analysis using RBP-EIA to determine serum RBP concentrations. National Institute of Standards and Technology and control sera were used to ensure quality and accuracy for each set of analyses. To classify VAD, the same cutoff point of o0.70 mmol/l was employed for each indicator. Results: Overall, the prevalence of VAD based on serum retinol was 22.3% (95% confidence interval (CI): 18.0, 26.6), whereas the RBP-EIA indicated a VAD prevalence of 20.9% (95% CI: 16.7, 25.1). A simple linear regression model indicated an R 2 of 0.79, and a receiver operating curve analysis revealed an area under the curve of 0.92. Conclusions: We found no significant difference between the results of RBP-EIA compared to retinol analyzed by HPLC in estimating the prevalence of VAD. Use of the test could enable public health authorities to assess the extent of VAD and track progress in control programs in resource-poor settings.
Introduction
In order to evaluate the impact of interventions aimed at controlling vitamin A deficiency (VAD), changes in the vitamin A (VA) status of populations must be determined. The Micronutrient Initiative and the United Nations Children's Fund estimate that over 140 million people worldwide are affected by VAD, representing a serious public health problem in many developing countries (MI/UNICEF, 1998). Worldwide, VAD directly contributes to blindness in at least half a million children and indirectly contributes to the deaths of an estimated 1.5-2 million children annually (Humphrey and West, 1992) . In order to address this public health challenge, many countries have implemented programs to prevent VAD. To track progress of interventions, the assessment of VAD is extremely important, but this has been difficult because the methods currently employed for the measurement of VA status are expensive and complex.
Clinical and biochemical indicators are commonly used to estimate the magnitude of VAD in populations. Clinical indicators, including xerophthalmia, are less sensitive than biochemical indicators in the identification of populations with marginal VAD (Sommer and West, 1996) . Serum retinol has been the most commonly used biochemical indicator of VA status and VAD. However, large sample volumes of serum, careful specimen collection and handling, and optimal storage conditions are all required for its analysis. In addition, the cost of high-performance liquid chromatography (HPLC) retinol analysis is high, and few laboratories in developing countries are equipped to perform retinol analysis using HPLC. Moreover, a recent HPLC proficiency evaluation measuring retinol and carotenoids in serum indicated that of the 16 participating laboratories, there was poor consistency in nine laboratories for which, within and between labs, the differences for retinol determinations were more than 10% (Brouwer et al., 2002) . Recently, retinolbinding protein (RBP) has been found to correlate closely with serum retinol in field studies assessing the prevalence of VAD (Gamble et al., 2001) . Total RBP in serum is in two forms, apo-RBP and holo-RBP, where the latter forms a complex with retinol and transthyretin (Blaner, 1989) . These two fractions cannot be distinguished by immunoassays; to do so requires more sophisticated platforms (Blaner, 1989) . However immunoassays such as the retinol-binding proteinenzyme immunoassay (RBP-EIA) are rapid and more convenient when compared to other assessment methods for determining VA status in populations. An advantage of assessing RBP is that it is relatively stable compared with retinol (Blaner, 1989) . In addition, as a serum protein, RBP lends itself to immunological detection methods, whereas metabolites such as retinol require more complex methods and equipment. This relative stability and the close molar relationship to retinol in serum has facilitated the use of RBP as a surrogate measure of retinol and as an indicator of VA status (Almekinder et al., 2000; Semba et al., 2002) .
Objectives
The aim of this study was to compare VA status of a subgroup of Cambodian children at risk for VAD using the RBP-EIA and serum retinol analyzed by HPLC.
Materials and methods

Specimen collection
Specimens were collected from over 2000 preschool children as part of a national micronutrient (MN) prevalence survey conducted by Helen Keller International, Cambodia, in conjunction with the Ministry of Health of Cambodia (Helen Keller International/Cambodia, 2001) . The survey was approved by the Ethical Committee of the Ministry of Health of the Government of Cambodia, and informed parental consent was obtained for all children who provided blood samples. The children were selected using a multistage cluster sampling process. In brief, the 20 rural provinces of the country were categorized into six zones based on health, socioeconomics, ecology and geography. Eighty-four communes were selected by random selection from half of the provinces in each zone, followed by additional commune selection based on probability proportional to population. From each commune 30 households with at least one child under 5 years of age were selected by interval sampling, and a random subsample of these was selected for the determination of biochemical retinol status. Using polypropylene syringes, blood was drawn by venipuncture from children aged 6 to 59 months; the blood was then ejected into glass serum-collection tubes and allowed to coagulate. Serum was then separated from the coagulated blood in the field by a portable battery-powered centrifuge. The serum from each subject was divided into two equal aliquots of approximately 1 ml each and transferred into freezer vials. All vials were frozen onsite using dry ice and were then shipped to Helen Keller International's Asia Pacific Regional Technical Support Facility in Jakarta, Indonesia, where they were stored at À721C until analysis.
Sample size calculation
The sample size needed to validate the RBP-EIA was calculated in order to detect differences of at least 4% in the prevalence of biochemical VAD, where the estimated prevalence was 20% at a significance level of 95%. Based on these parameters, we determined that data from a matched panel of at least 385 children would be required. This number of serum specimens was selected by random sampling from approximately 2000 total vials stored in 100-tube arrays. Of the 385 samples selected, 26 were found to contain inadequate serum volume and were not included in the analysis, and there were no detectable differences between the characteristics of the excluded children and the remaining 359 in terms of age and gender.
Laboratory procedures
On each day the assays were carried out, one box containing a portion of the randomly selected serum samples was removed from the freezer. These specimens were allowed to thaw at room temperature (18-251C) for approximately 40 min. To reduce error owing to potential sample degradation, precautions were taken to ensure that only a single box was thawed at any time. After the samples thawed, they were mixed on a vortex mixer and stored on ice until the assays were completed. The RBP-EIA and retinol-HPLC determinations were completed sequentially on all specimens in the box, and the remainder of the sera in the tubes was then immediately returned to cryostorage. Four samples were excluded from analysis because they were badly hemolyzed or had insufficient volumes. No other diagnostic tests were performed during this evaluation.
Analysis of RBP-EIA
To perform the assay, the specimens and calibrator sera were diluted 1:25 in assay buffer (phosphate-buffered saline containing Tween 20 and bovine serum albumin) in a lowprotein binding microwell plate (Nalge Nunc International, Rochester, NY, USA). Once the specimens and calibrator sera (Dade Behring, Deerfield, IL, USA) were diluted, they were mixed by reverse pipetting, and 100 ml were transferred to the test wells in duplicate. Then 100 ml of monoclonal anti-RBP antibody, conjugated to horseradish peroxidase enzyme diluted 1:8000, were immediately added to the test wells. The test was incubated for 15 min at room temperature (18-251C) and mixed at 10 min after starting the incubation by gently tapping the plate frame. Following the 15-min incubation, test plates were inverted and the contents emptied into a sink. The test wells were then washed five times using wash buffer. Immediately following the final wash, the wells were inverted and tapped dry onto absorbent paper. Then, 200 ml of 3,3 0 5,5 0 tetramethylbenzidine containing hydrogen peroxide substrate (Ultra-Sensitive, Moss Inc., Hanover, MD, USA) were added to each well. The plates were then incubated at room temperature (181C-251C) for another 10 min; after 5 min of incubation, the reagents were mixed again by gently tapping the plate frame. Following this second incubation, 100 ml of stop solution (1% HCl (v/v)) were added to all of the test wells. The plates were immediately read using an enzyme immunoassay plate reader (Revelation, Dynex, Chantilly, VA, USA) fitted with a 450 nm filter, and the resulting optical densities were recorded.
The results from the analyses were compared to values obtained from the calibrator sera by linear regression software (Softmax Pro V4.5, Revelation, Dynex, Chantilly, VA, USA). Test results were available in as few as 40 min after the start of the assay.
Analysis of retinol-HPLC
The HPLC system (Shimadzu, LC, Kyoto, Japan) used for serum retinol analysis included two dual-head pumps (LC10Advp), a programmable UV/VIS detector (SPD-10AVvp), a column oven, system controller (SCL-10Avp) and an autosampler (SIL-10Advp). The data from each determination were transmitted, stored and processed by personal computer using Shimadzu's data reduction software. Retinol determinations were performed using a commercially available VA and vitamin E determination kit (Bio-Rad A/E, BioRad Inc., Hercules, CA, USA).
Statistical methods
Serum retinol values analyzed by HPLC were compared to RBP concentrations quantified by the RBP-EIA. Data from each assay were examined using the EpiInfo for Windows software (Centers for Disease Control and Prevention, Atlanta, GA, USA) to determine the percentage of VAD in the population based on international recommended cutoff points (WHO/UNICEF, 1996) . A receiver operating curve (ROC) curve was plotted to determine the most appropriate cutoff point for value of RBP in estimating the prevalence of VAD using different cutoff criteria when compared to retinol o0.70 mmol/l (Zweig and Campbell, 1993) . This analytical tool provides a graphic representation of the balance between sensitivity and specificity, such that the closer the curve follows the left vertical axis and the top horizontal axis of the ROC space, the more accurate the test. In turn, the area under the curve is a measure of the overall test accuracy (Analyse-It Software Ltd, Leeds, England, 2003) .
This secondary analysis of data from Cambodia was approved by a Human Subjects Protection Committee at PATH and did not include any individual identification information that could have compromised the confidentiality of the original study participants.
Results
Percentage of VAD in the population detected by each test
The prevalence of VAD based on retinol was 22.3% (95% confidence interval (CI): 18.0, 26.6), whereas the prevalence of VAD using the RBP-EIA was 20.9% (95% CI: 16.7, 25.1) ( Table 1) . In both cases, the same cutoff point of o0.70 mmol/l was used. The difference between these two prevalence estimates was not statistically significant. In this population, there was a higher prevalence of severe VAD when using retinol (o0.35 mmol/l; 2.2%, 95% CI: 0.7, 3.8) than when estimated using the RBP-EIA (0.6%, 95% CI: 0.0, 1.3).
Accuracy of RBP-EIA as compared to serum retinol determined by HPLC The sensitivity and specificity of the RBP-EIA to predict VAD based on low retinol values was estimated using the cutoff value of 0.70 mmol/l for both RBP and retinol (Table 2 ). In addition, the RBP-EIA values for each specimen were plotted against their corresponding retinol HPLC values. From the scatter plot, a linear regression model was fitted with an R 2 ¼ 0.78. The area under the ROC curve equaled 0.92 (Figure 1 ). The RBP-EIA gave a sensitivity of 70% and specificity of 93.2%. These results are well within the range that can be expected when comparing two test methods for different analytes.
Discussion
Using serum specimens collected from preschool children for a national MN survey in Cambodia, we observed that the results of the RBP-EIA closely correlated with results of retinol determination by HPLC. In this study, we found that 22.3% of the population was VA deficient by measuring retinol, whereas we found a VAD prevalence of 20.9% by measuring RBP. Although the difference in estimates of severe VAD was more pronounced with retinol leading to a high prevalence, the main aim of the RBP-EIA is to discriminate between deficiency at the higher cutoff point of retinol o0.70 mmol/l. To further demonstrate the prognostic capacity of RBP to estimate retinol, we calculated the sensitivity and specificity to determine the ability of the RBP-EIA to accurately screen children as compared with retinol-HPLC values taken as the reference standard.
The analysis led to a sensitivity of 70% and specificity of 93.2% in which the same cutoff point of o0.70 mmol/l was adopted for both parameters. Furthermore, analysis of the ROC curve indicated a very close association between serum retinol and RBP. The ROC curve for an ideal test plots a true positive rate equal to one; a true negative rate equal to zero would, therefore, produce an area under the curve equal to one. The area under the ROC curve measuring the association between RBP at different cutoff points and retinol was 0.92. Linear regression models are commonly used to demonstrate the correspondence between two variables expressed on a continuous scale. In our analysis, an R 2 of 0.79 was observed between RBP and retinol. The regression plot reveals, in addition to an R 2 of 0.79, a slope of 0.65 and an intercept of 0.27, indicating that the association of comparison between retinol and RBP is not a clear 1:1 molar relationship and thus also does not pass through the origin of the plot. It is possible that the variation may be owing to the different proportions of holo-and apo-RBP in circulation, which is being detected as total RBP by the immunoassay versus total retinol by HPLC. This was also confirmed by the ROC and further suggests that using the same cutoff for RBP and retinol may be inappropriate. RBP is a more stable biological compound than retinol. As a protein, RBP does not appear to be as sensitive to environmental conditions, including sunlight, heat and other conditions that have been found to degrade retinol (Tietz, 1995) . These properties would make sample preparation and shipment easier for field assessment teams.
Alternative methods for retinol and RBP determination have been used in assessment studies, including the Futterman fluorescence method for retinol (Futterman et al., 1975) radioimmunoassay (Malvy et al., 1993) and more complicated, less rapid, conventional EIA methods for RBP (Immunodiagnostik AG, Bensheim, Germany), (MacCrehan and Schonberger, 1987) .
Retinol determination by HPLC is widely seen as the most accurate method for laboratory analysis (de Pee and Dary, 2002) . Unfortunately, HPLC equipment and systems are very expensive to maintain and operate and require significant investment in training and time; they are relatively slow and labor-intensive. For example, in this study we used the commercially available BioRad HPLC vitamin A/E determination kit (BioRad, Hercules, CA, USA), a relatively simple method, permitting one laboratory technician to analyze 40-50 specimens per day, compared to 20-30 specimens per day with conventional protocols. By comparison, 40-50 specimens could be analyzed by RBP-EIA in less than 1 h and Rapid enzyme immunoassay in assessing vitamin A status J Hix et al at a significantly lower cost than the BioRad kit used in this study (Hix et al., 2004) . The RBP-EIA, therefore, increases throughput of samples, decreases the time needed to return results, and provides results at a lower cost when compared to the determination of serum retinol concentrations by HPLC. Implementation of the RBP-EIA in many countries is likely to be relatively straightforward as HIV diagnosis and monitoring by EIA is routine in many developing countries and thus many reference laboratories already possess EIA plate readers and washers. EIA equipment is more widely available than HPLC systems. If a simple plate-washing device and a portable EIA strip-well reader are employed, the RBP-EIA could also be adapted for field use. The cost associated with the implementation of the RBP-EIA was approximately US$3 per determination (per subject given duplicate runs per subject). Consequently, the RBP-EIA is less expensive than the measurement of serum retinol by HPLC, which costs at least US$15 to US$20 for each determination.
When this rapid, inexpensive and robust method for the determination of VAD is commercially available, it may provide health-care managers with an effective tool to assess the extent of VAD within a population. We expect that the RBP-EIA will facilitate the monitoring and evaluation of VA status and increase the number of countries that can conduct prevalence surveys to assess VAD, especially in those countries where such surveys have not yet been carried out but where the need may be the greatest. When this method becomes available (estimated March 2006 from Scimedx Corp., Denville, NJ, USA) to health-care managers, more data will be generated to establish the validity of this test across diverse population settings.
This evaluation of 359 sera was performed in conjunction with Helen Keller International in their technical support facility in Jakarta, Indonesia. The data indicate an excellent relationship between serum retinol and RBP concentrations in this specimen population. The data confirm earlier reports (Gamble et al., 2001 ) that RBP is an acceptable surrogate marker for evaluating VAD status in populations. The RBP-EIA is a rapid and relatively inexpensive tool for the quantification of RBP. It may be used under a variety of conditions, such as in provincial or district hospital laboratories, or by trained epidemiological surveillance teams in the field. It can allow health-care workers to assess rapidly the extent of VAD in a population to determine the need for supplementation.
